Monitoring and management of heparin-induced thrombocytopenia

British Journal of Hospital Medicine

Volumn 70, Issue 11, 2009, Pages 630-633

  Rogers Trauma, B A ^a   Little, N J ^a   Jones, C ^b  

^a Northern Deanery   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 72949101220     PISSN: 17508460     EISSN: None     Source Type: Journal    
DOI: 10.12968/hmed.2009.70.11.45051     Document Type: Review

References (19)

1. AntonelliD,FaresL,AneneC(2000) Enoxaparinassociatedwithhughabdominalwallhematomas:areportoftwocases.AmSurg66(8) :797-800(Pubitemid30626875)
2. Baglin T, Barrowcliffe TW, Cohen A, Greaves M (2006) Guidelines on the use and monitoring of heparin. Br J Haematol 133(1): 19-34
3. Bidder P, Brandes J, Lee M, Bozic K, Chesbro B, Claassen J (2006) Bleeding complications from femoral and sciatic nerve catheters in patients receiving low molecular weight heparin. Anesth Analg 103(4): 1036-1037
4. Burgess JK, Lindeman R, Chesterman CN, Chong BH (1995) Single amino acid mutation of Fc gamma receptor is associated with the development of heparin-induced thrombocytopenia. Br J Haematol 91(3): 761-766
5. Chong BH (1995) Heparin-induced thrombocytopenia. Br J Haematol 69(3): 431-9
6. Dickinson LD, Miller LD, Patel CP, Gupta SK (1998) Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery 43(5): 1074-1081
7. FarnerB,EichlerP,KrollH,GreinacherA(2001) Acomparisonofdanaparoidandlepirudininheparin-inducedthrombocytopenia. ThrombHaemost85(6):950-957(Pubitemid32573742)
8. Houde JP, Steinberg G (1999) Intrahepatic hemorrhage after use of low-molecular-weight heparin for total hip arthroplasty. J Arthroplasty 14(3): 372-374 (Pubitemid 29172255)
9. Imberti D, Ageno W, Dentali F, Giorgi Pierfranceschi M, Croci E, Garcia D (2006) Management of primary care patients with suspected deep vein thrombosis: use of a therapeutic dose of low-molecular-weight heparin to avoid urgent ultrasonographic evaluation. J Thromb Haemost 4(5): 1037-1041
10. Joint Formulary Committee (2006) Parenteral anticoagulants. In: British National Formulary [51]. British Medical Association and Royal Pharmaceutical Society of Great Britain, London: 119-122
11. King DJ, Kelton JG (1984) Heparin-associated thrombocytopenia. Ann Intern Med 100(4): 535-540
12. Leyvraz PF, Bachmann F, Hoek J, Bullet HR, Postel M, Samama M, Vandenbroek MD (1991) Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. BMJ 303(6802): 543-548
13. Lilikakis AK, Papapolychroniou T, Mâcheras G, Michelinakis E (2006) Thrombocytopenia and intra-cerebral complications associated with low-molecular-weight heparin treatment in patients undergoing total hip replacement. A report of two cases. J Bone Joint Surg Am 88(3): 634-638
14. Mohr DN, Silverstein MD, Murtaugh PA, Harrison JM (1993) Prophylactic agents for venous thrombosis in elective hip surgery. Meta-analysis of studies using venographic assessment. Arch Intern Med 153(19): 2221-2228
15. Shaieb MD, Watson BN, Atkinson RE (1999) Bleeding complications with enoxaparin for deep venous thrombosis prophylaxis. J Arthroplasty 14(4): 432-438 (Pubitemid 29329795)
16. Srern SH, Wixson RL, O'Connor D (2000) Evaluation of the safety and efficacy of enoxaparin and warfarin for prevention of deep vein thrombosis after total knee arthroplasty. J Arthroplasty 15(2): 153-158
17. Warkentin TE (1999) Heparin-induced thrombocytopenia: a clinicopathologic syndrome. Thromb Haemost 82(2): 439-447
18. Warkentin TE, Heddle NM (2003) Laboratory diagnosis of immune heparin-induced thrombocytopenia. Curr Hematol Rep 2(2): 148-157
19. Wolf H (1994) Low-molecular-weight heparin. Med Clin North Am 78(3): 733-743